BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 20172376)

  • 21. Oncogene amplification and overexpression of oncoproteins in thyroid papillary cancer.
    Várkondi E; Gyory F; Nagy A; Kiss I; Ember I; Kozma L
    In Vivo; 2005; 19(2):465-70. PubMed ID: 15796211
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Immunohistochemical analysis of p27/kip1 expression in thyroid carcinoma.
    Resnick MB; Schacter P; Finkelstein Y; Kellner Y; Cohen O
    Mod Pathol; 1998 Aug; 11(8):735-9. PubMed ID: 9720501
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Peroxisome proliferator activated receptor gamma immunohistochemical expression in human papillary thyroid carcinoma tissues. Possible relationship to lymph node metastasis.
    Galusca B; Dumollard JM; Chambonniere ML; Germain N; Prades JM; Péoc'h M; Estour B
    Anticancer Res; 2004; 24(3b):1993-7. PubMed ID: 15274390
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Expression of Bax, p53, and p27/kip in patients with papillary thyroid carcinoma with or without cervical nodal metastasis.
    Karlidag T; Cobanoglu B; Keles E; Alpay HC; Ozercan I; Kaygusuz I; Yalcin S; Sakallioglu O
    Am J Otolaryngol; 2007; 28(1):31-6. PubMed ID: 17162129
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Immunohistochemical expression of cyclin D1, E2F-1, and Ki-67 in benign and malignant thyroid lesions.
    Saiz AD; Olvera M; Rezk S; Florentine BA; McCourty A; Brynes RK
    J Pathol; 2002 Oct; 198(2):157-62. PubMed ID: 12237874
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Correlation of cyclin D1 and E1 expression with bladder cancer presence, invasion, progression, and metastasis.
    Shariat SF; Ashfaq R; Sagalowsky AI; Lotan Y
    Hum Pathol; 2006 Dec; 37(12):1568-76. PubMed ID: 16949911
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Expression of cell-cycle regulatory proteins cyclin D1, cyclin E, and their inhibitor p21 WAF1/CIP1 in gastric cancer.
    Müller W; Noguchi T; Wirtz HC; Hommel G; Gabbert HE
    J Pathol; 1999 Oct; 189(2):186-93. PubMed ID: 10547573
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Expression and significance of VEGF, VEGF-C, and VEGF-D in papillary thyroid carcinoma].
    Jiang HG; Gao M; Tang WP; Li FH; Cai QZ
    Ai Zheng; 2005 Sep; 24(9):1136-9. PubMed ID: 16159441
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The Wnt/β-catenin pathway drives increased cyclin D1 levels in lymph node metastasis in papillary thyroid cancer.
    Zhang J; Gill AJ; Issacs JD; Atmore B; Johns A; Delbridge LW; Lai R; McMullen TP
    Hum Pathol; 2012 Jul; 43(7):1044-50. PubMed ID: 22204713
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Cell cycle regulators in bladder cancer: relationship to schistosomiasis.
    Eissa S; Ahmed MI; Said H; Zaghlool A; El-Ahmady O
    IUBMB Life; 2004 Sep; 56(9):557-64. PubMed ID: 15590562
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Galectin-3 expression in papillary thyroid carcinoma: relation to histomorphologic growth pattern, lymph node metastasis, extrathyroid invasion, and tumor size.
    Cvejic DS; Savin SB; Petrovic IM; Paunovic IR; Tatic SB; Havelka MJ
    Head Neck; 2005 Dec; 27(12):1049-55. PubMed ID: 16155918
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Analysis of cyclin D1 and retinoblastoma protein immunoreactivity in follicular thyroid tumors.
    Ferenc T; Lewiński A; Lange D; Niewiadomska H; Sygut J; Sporny S; Jarzab B; Satacińska-Los E; Kulig A; Włoch J
    Pol J Pathol; 2005; 56(1):27-35. PubMed ID: 15921011
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Immunohistochemical characterization of p57KIP2 expression in human esophageal squamous cell carcinoma.
    Matsumoto M; Furihata M; Ohtsuki Y; Sasaguri S; Ogoshi S
    Anticancer Res; 2000; 20(3B):1947-52. PubMed ID: 10928132
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Expression and significance of cell cycle regulators in gastric carcinoma].
    Wu JF; Shao JC; Wang DB; Qin R; Zhang H
    Ai Zheng; 2005 Feb; 24(2):175-9. PubMed ID: 15694028
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Loss of Raf-1 kinase inhibitor protein expression is associated with lymph node metastasis in papillary thyroid cancer.
    Eun YG; Kim SW; Kim YW; Kwon KH
    Otolaryngol Head Neck Surg; 2010 Oct; 143(4):544-8. PubMed ID: 20869566
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Decreased type 1 iodothyronine deiodinase expression might be an early and discrete event in thyroid cell dedifferentation towards papillary carcinoma.
    de Souza Meyer EL; Dora JM; Wagner MS; Maia AL
    Clin Endocrinol (Oxf); 2005 Jun; 62(6):672-8. PubMed ID: 15943828
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of P57(kip2) and cyslinE proteins in human pancreatic cancer.
    Yue H; Yu J; Zhao X; Song F; Feng X
    Chin Med J (Engl); 2003 Jun; 116(6):944-6. PubMed ID: 12877813
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Decreased immunoreactivity for p27 protein in patients with early-stage breast carcinoma is correlated with HER-2/neu overexpression and with benefit from one course of perioperative chemotherapy in patients with negative lymph node status: results from International Breast Cancer Study Group Trial V.
    Spataro VJ; Litman H; Viale G; Maffini F; Masullo M; Golouh R; Martinez-Tello FJ; Grigolato P; Shilkin KB; Gusterson BA; Castiglione-Gertsch M; Price K; Lindtner J; Cortés-Funes H; Simoncini E; Byrne MJ; Collins J; Gelber RD; Coates AS; Goldhirsch A;
    Cancer; 2003 Apr; 97(7):1591-600. PubMed ID: 12655514
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Reduced E-cadherin expression contributes to the loss of p27kip1-mediated mechanism of contact inhibition in thyroid anaplastic carcinomas.
    Motti ML; Califano D; Baldassarre G; Celetti A; Merolla F; Forzati F; Napolitano M; Tavernise B; Fusco A; Viglietto G
    Carcinogenesis; 2005 Jun; 26(6):1021-34. PubMed ID: 15718252
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Expression patterns of cyclins D1, E in laryngeal epithelial lesions: correlation with other cell cycle regulators (p53, pRb, Ki-67 and PCNA) and clinicopathological features.
    Ioachim E; Peschos D; Goussia A; Mittari E; Charalabopoulos K; Michael M; Salmas M; Vougiouklakis T; Assimakopoulos D; Agnantis NJ
    J Exp Clin Cancer Res; 2004 Jun; 23(2):277-83. PubMed ID: 15354413
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.